Tokyo, March 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061018) titled 'A randomized, open-label, crossover comparison study for the effects of consumption of frozen dessert on blood glucose levels' on March 23.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Placebo
Primary Sponsor:
Institute - Morinaga Milk Industry CO., LTD.
Condition:
Condition - Healthy Japanese
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the efficacy of frozen dessert in blood glucose levels management in healthy individuals.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Control food -> The test food1 -> The test food2
*Take each test food over five min
Interventions/Control_2 - Control food -> The test food2 -> The test food1
*Take each test food over five min
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - 1. Men and women aged 20 or more and less than 65 at the time of agreement to participate in this study
Key exclusion criteria - 1. Individuals whose fasting blood glucose level is 126 mg/dL or more at screening (Scr)
2. Individuals whose hemoglobin A1c (HbA1c) is 6.5% or more at Scr
3. Individuals who take medicines that may influence the blood glucose level
4. Individuals who are currently taking "Foods for Specified Health Uses" or "Foods with Function Claims"
5. Individuals who are undergoing medical treatment or have a serious medical history of any disease such as liver, kidney, heart, lung, digestive organ, blood, endocrine system, or metabolic system
6. Individuals who have drug allergy or food allergy (such as eggs, milk ingredients, soybeans)
7. Individuals who are pregnant, planning to become pregnant during this study, or lactating
8. Individuals who are collected 400 mL or more of blood due to blood donation within 8 weeks before the agreement to participate in this study
9. Individuals who are dental decay or hypersensitive teeth
10. Individuals who are participating in other clinical trials or plan to participate in another study during this study
11. Individuals who are judged as ineligible to participate in this study based on the results of participant' background, physical finding, consultation, physical examination, and clinical examination, by principal physician or sub-physician
Target Size - 18
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 03 Month 11 Day
Date of IRB - 2026 Year 03 Month 11 Day
Anticipated trial start date - 2026 Year 03 Month 23 Day
Last follow-up date - 2026 Year 08 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069822
Disclaimer: Curated by HT Syndication.